SLC39A11 and ovarian cancer: Patients of cervical and ovarian cancers represent the groups with larger numbers in ZIP11 mutations, however mutations on this gene are not considered to be a prognostic marker of the disease (Figure 1 and Supplementary Figure S1 and Supplementary Table S3).